IMPACT OF TOCILIZUMAB THERAPY ON STRUCTURAL JOINT DAMAGE PROGRESSION IN RHEUMATOID ARTHRITIS

Objective — to evaluate the impact of tocilizumab (TCZ) therapy on progression of joint destruction and rheumatoid arthritis (RA) inflammatory activity in 48 weeks after initiation of treatment. Material and methods. 42 RA patients who received 6 intravenous TCZ infusions at dose 8 mg/kg given once...

Full description

Saved in:
Bibliographic Details
Main Authors: Anastasia Sergeevna Avdeeva, A V Smirnov, E Yu Panasyuk, E N Alexandrova, E L Nasonov
Format: Article
Language:Russian
Published: IMA PRESS LLC 2012-10-01
Series:Научно-практическая ревматология
Subjects:
Online Access:https://rsp.mediar-press.net/rsp/article/view/1090
Tags: Add Tag
No Tags, Be the first to tag this record!